Literature DB >> 33834397

Challenges and Strategies for Current Classifications of Depressive Disorders: Proposal for Future Diagnostic Standards.

Seon-Cheol Park1, Yong-Ku Kim2.   

Abstract

The Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition (DSM-IV) was revised based on a combination of a categorical and a dimensional approach such that in the DSM, Fifth Edition (DSM-5), depressive disorders have been separated as a distinctive disease entity from bipolar disorders, consistent with the deconstruction of Kraepelinian dualism. Additionally, the diagnostic thresholds of depressive disorders may be reduced due to the addition of "hopelessness" to the subjective descriptors of depressed mood and the removal of the "bereavement exclusion." Manic/hypomanic, psychotic, and anxious symptoms in major depressive disorder (MDD) and other depressive disorders are described using the transdiagnostic specifiers of "with mixed features," "with psychotic features," and "with anxious distress," respectively. Additionally, due to the polythetic and operational characteristics of the DSM-5 diagnostic criteria, the heterogeneity of MDD is inevitable. Thus, 227 different symptom combinations fulfill the DSM-5 diagnostic criteria for MDD. This heterogeneity of MDD is criticized in view of the Wittgensteinian analogy of language game. Depression subtypes determined by disturbances in monoamine levels and the severity of the disease have been identified in the literature. According to a review of the Gottesman and Gould criteria, neuroticism, morning cortisol, cortisol awakening response, asymmetry in frontal cortical activity on electroencephalography (EEG), and probabilistic reward learning, among other variables, are evidenced as endophenotypes for depressive disorders. Network analysis has been proposed as a potential method to compliment the limitations of current diagnostic criteria and to explore the pathways between depressive symptoms, as well as to identify novel and interesting relationships between depressive symptoms. Based on the literature on network analysis in this field, no differences in the centrality index of the DSM and non-DSM symptoms were repeatedly present among patients with MDD. Furthermore, MDD and other depressive syndromes include two of the Research Domain Criteria (RDoC), including the Loss construct within the Negative Valence Systems domains and various Reward constructs within the Positive Valence Systems domain.

Entities:  

Keywords:  Depressive disorders; Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); Heterogeneity; Major depressive disorder (MDD); Network analysis; Research Domain Criteria (RDoC)

Mesh:

Year:  2021        PMID: 33834397     DOI: 10.1007/978-981-33-6044-0_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  53 in total

1.  The validity of the severity-psychosis hypothesis in depression.

Authors:  Søren Dinesen Østergaard; Jim Bille; Henrik Søltoft-Jensen; Nils Lauge; Per Bech
Journal:  J Affect Disord       Date:  2012-03-03       Impact factor: 4.839

2.  The status quo as a good outcome: How the DSM-5 diagnostic criteria for generalized anxiety disorder remained unchanged from the DSM-IV criteria.

Authors:  Vladan Starcevic; Michael E Portman
Journal:  Aust N Z J Psychiatry       Date:  2013-09-11       Impact factor: 5.744

3.  Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5.

Authors:  David J Kupfer; Darrel A Regier
Journal:  Am J Psychiatry       Date:  2011-07       Impact factor: 18.112

4.  Medicine. Brain disorders? Precisely.

Authors:  Thomas R Insel; Bruce N Cuthbert
Journal:  Science       Date:  2015-05-01       Impact factor: 47.728

5.  Classification of Psychiatric Disorders.

Authors:  Yong-Ku Kim; Seon-Cheol Park
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

6.  Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response.

Authors:  Thaddeus S Block; Harvey Kushner; Ned Kalin; Craig Nelson; Joseph Belanoff; Alan Schatzberg
Journal:  Biol Psychiatry       Date:  2018-01-31       Impact factor: 13.382

7.  Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study.

Authors:  Mario Maj; Raffaele Pirozzi; Lorenza Magliano; Andrea Fiorillo; Luca Bartoli
Journal:  J Clin Psychiatry       Date:  2007-09       Impact factor: 4.384

Review 8.  Major depressive disorder in DSM-5: implications for clinical practice and research of changes from DSM-IV.

Authors:  Rudolf Uher; Jennifer L Payne; Barbara Pavlova; Roy H Perlis
Journal:  Depress Anxiety       Date:  2013-11-22       Impact factor: 6.505

9.  Diagnostic Issues of Depressive Disorders from Kraepelinian Dualism to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.

Authors:  Seon-Cheol Park; Yong-Ku Kim
Journal:  Psychiatry Investig       Date:  2019-09-23       Impact factor: 2.505

10.  Contemporary Issues in Depressive Disorders.

Authors:  Seon-Cheol Park; Yong-Ku Kim
Journal:  Psychiatry Investig       Date:  2019-09-23       Impact factor: 2.505

View more
  2 in total

Review 1.  The Entorhinal Cortex and Adult Neurogenesis in Major Depression.

Authors:  Il Bin Kim; Seon-Cheol Park
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

2.  TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms.

Authors:  Hongmei Liu; Xiaohui Wu; Yun Wang; Xiaohua Liu; Daihui Peng; Yan Wu; Jun Chen; Yun'ai Su; Jia Xu; Xiancang Ma; Yi Li; Jianfei Shi; Xiaodong Yang; Han Rong; Marta Di Forti; Yiru Fang
Journal:  Gen Psychiatr       Date:  2022-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.